Virbac SA (EPA:VIRP)
France · Delayed Price · Currency is EUR 360.00
-2.00 (-0.55%)
May 22, 2026, 5:35 PM CET
Virbac Revenue
In the year 2025, Virbac had annual revenue of 1.46B EUR with 4.82% growth. Virbac had revenue of 726.40M in the half year ending December 31, 2025, with 14.14% growth.
Revenue
1.46B
Revenue Growth
+4.82%
P/S Ratio
2.06
Revenue / Employee
227.36K
Employees
6,442
Market Cap
3.02B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.46B | 67.30M | 4.82% |
| Dec 31, 2024 | 1.40B | 150.48M | 12.07% |
| Dec 31, 2023 | 1.25B | 30.71M | 2.53% |
| Dec 31, 2022 | 1.22B | 152.22M | 14.31% |
| Dec 31, 2021 | 1.06B | 129.77M | 13.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sanofi | 47.35B |
| EssilorLuxottica Société anonyme | 28.49B |
| emeis Société anonyme | 5.90B |
| Ramsay Générale de Santé | 5.36B |
| Clariane SE | 5.31B |
| bioMérieux | 4.07B |
| Ipsen | 3.93B |
| Sartorius Stedim Biotech | 2.98B |
Virbac News
- 15 days ago - Virbac : Declaration of the number of shares and voting rights 04/2026 - GlobeNewsWire
- 25 days ago - Virbac : Public release of Virbac Annual Report at 31 December 2025. - GlobeNewsWire
- 5 weeks ago - Virbac: strong Q1 2026 growth of +7.7% at CERS, driven by double-digit growth of our priority Supercharge4 platforms - GlobeNewsWire
- 5 weeks ago - Virbac Earnings release: Q1 2026 - Filings
- 6 weeks ago - Virbac : Declaration of the number of shares and voting rights 03/2026 - GlobeNewsWire
- 2 months ago - Virbac Earnings Call Transcript: H2 2025 - Transcripts
- 2 months ago - Virbac Earnings release: H2 2025 - Filings
- 2 months ago - Virbac Slides: H2 2025 - Filings